Methods Patients with a 2-15 cm BE with low-grade dysplasia (LGD), high-grade dysplasia
(HGD) or early cancer (EC) were included. Visible lesions were removed by endoscopic …

The need to combat the rising incidence of esophageal adenocarcinoma with its dismal
prognosis has led to increasing development of many endoscopic treatments for Barrett's …

Background Long-term durability data for radiofrequency ablation (RFA) to prevent
esophageal adenocarcinoma in long-segment (LSBE) and ultralong-segment Barrett's …

Discussion The optimal management of dysplastic BE continues to evolve. Patient, disease
characteristics, local expertise, and available resources often dictate the treatment modality …

Background and Aims Barrett's esophagus with low-grade dysplasia (BE-LGD) carries a risk
of progression to Barrett's esophagus with high-grade dysplasia (BE-HGD) and esophageal …

Background Radiofrequency ablation (RFA) is an effective means of eradicating Barrett's
esophagus (BE), both with and without associated dysplasia. Several studies have …

Barrett's esophagus (BE) can progressively lead to the development of low-grade dysplasia
(LGD), high-grade dysplasia (HGD), intramucosal carcinoma (IMC), and advanced …

Endoscopic mucosal resection and RFA are the cornerstones in the management of
dysplasia and early EAC in Barrett's esophagus patients today. Despite the encouraging …

BACKGROUND & AIMS: Radiofrequency ablation (RFA) is an established treatment for
dysplastic Barrett's esophagus (BE). Although short-term end points of ablation have been …

Objective Radiofrequency ablation (RFA)±endoscopic resection (ER) is the preferred
treatment for early neoplasia in Barrett's oesophagus (BE). We aimed to report short-term …